IP question may not be fully resolved in everyone's mind.
If you mean the IP issues for EOLS that would be bullish for RVNC if it becomes an issue
If you mean there are IP issues related to the RVNC product that is another story. I honestly don't know how the company got their botox strain and if you are intimating that allergan could come after them like they are evolus that *might* explain some of this post eols call action, but RVNC does have considerable IP around the daxi formulation itself